Cite
Kefeli U, Benekli M, Sevinc A, et al. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. Oncol Lett. 2013;6(2):605-611doi: 10.3892/ol.2013.1408.
Kefeli, U., Benekli, M., Sevinc, A., Yildiz, R., Kaplan, M. A., Ciltas, A., Balakan, O., Isikdogan, A., Coskun, U., Dane, F., Harputluoglu, H., Karaca, H., Yazilitas, D., Durnali, A., Kaya, A. O., Demirci, U., Gumus, M., & Buyukberber, S. (2013). Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. Oncology letters, 6(2), 605-611. https://doi.org/10.3892/ol.2013.1408
Kefeli, Umut, et al. "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience." Oncology letters vol. 6,2 (2013): 605-611. doi: https://doi.org/10.3892/ol.2013.1408
Kefeli U, Benekli M, Sevinc A, Yildiz R, Kaplan MA, Ciltas A, Balakan O, Isikdogan A, Coskun U, Dane F, Harputluoglu H, Karaca H, Yazilitas D, Durnali A, Kaya AO, Demirci U, Gumus M, Buyukberber S. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. Oncol Lett. 2013 Aug;6(2):605-611. doi: 10.3892/ol.2013.1408. Epub 2013 Jun 17. PMID: 24137379; PMCID: PMC3789037.
Copy
Download .nbib